News

Ailsa Craig and Marek Poszepczynski, portfolio managers at the International Biotechnology Trust, tell MoneyWeek where they’d ...
To properly understand Krystal Biotech's profit results, we need to consider the US$25m expense attributed to unusual items. It's never great to see unusual items costing the company profits ...
So, here we are, launching our fourth edition of Fierce Biotech's layoff tracker. As always, if you know of a layoff occurring at a biotech, please reach out to the Fierce Biotech editorial team ...
The founder and former leader of Inhibikase Therapeutics is blazing a new biotech trail in an effort to get a beleaguered Parkinson’s candidate over the finish line. Milton Werner, Ph.D., is the ...
LONDON, May 14 (Reuters) - Some U.S. biotech companies are considering moving early-stage trials of new medicines outside the United States as worry grows that layoffs and policy changes at the ...
Peter Diamandis, the entrepreneur behind the XPrize Foundation, has long championed a future of technological promise, building a career on innovation competitions meant to solve grand challenges.
Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Merck has held talks over a more than $3bn acquisition of Swiss biotechnology group MoonLake ...
STOCKHOLM, May 20, 2025 /PRNewswire/ -- Skanska has signed an additional contract with the University of Virginia for the construction of the Paul and Diane Manning Institute of Biotechnology at ...
Despite this fact, social media followers reacted to fake images of the singer-songwriter at the 2025 gala, not realizing that the outfit they were so passionately denouncing was AI-generated.
(RTTNews) - As May draws to a close, it's time to turn our attention to the FDA's upcoming slate of decisions. From January through May 2025, the U.S. regulatory agency has approved 13 novel drugs ...